Stress Kinases in the Modulation of Metabolism and Energy Balance

Overview

Journal J Mol Endocrinol

Specialties Endocrinology
Molecular Biology

Date 2015 Sep 13

PMID 26363062

Citations 38

Authors

Elisa Manieri

Guadalupe Sabio

Affiliations

Soon will be listed here.

Abstract

Obesity is a new global pandemic, with growing incidence and prevalence. This disease is associated with increased risk of several pathologies, including diabetes, cardiovascular diseases, and cancer. The mechanisms underlying obesity-associated metabolic changes are the focus of efforts to identify new therapies. Stress-activated protein kinases (SAPK), including cJun N-terminal kinases (JNKs) and p38, are required for cellular responses to metabolic stress and therefore might contribute to the pathogenesis of obesity. Tissue-specific knockout models support a cell-type-specific role for JNK isoforms, in particular JNK1, highlighting its importance in cell homeostasis and organ crosstalk. However, more efforts are needed to elucidate the specific roles of other JNK isoforms and p38 family members in metabolism and obesity. This review provides an overview of the role of SAPKs in the regulation of metabolism.

Citing Articles

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.

Olloquequi J, Ettcheto M, Cano A, Fortuna A, Bicker J, Sanchez-Lopez E Int J Mol Sci. 2023; 24(18).

PMID: 37762479 PMC: 10531537. DOI: 10.3390/ijms241814177.

Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11-Indeno[1,2-]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime.

Matveevskaya V, Pavlov D, Kovrizhina A, Sukhikh T, Sadykov E, Dorovatovskii P Pharmaceutics. 2023; 15(7).

PMID: 37513989 PMC: 10383563. DOI: 10.3390/pharmaceutics15071802.

Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver.

Thapa K, Kadiri J, Saukkonen K, Pennanen I, Ghimire B, Cai M Elife. 2023; 12.

PMID: 37490042 PMC: 10368426. DOI: 10.7554/eLife.84782.

Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis.

Shao Y, Tian J, Yang Y, Hu Y, Zhu Y, Shu Q Front Neurosci. 2022; 16:931161.

PMID: 35992905 PMC: 9389235. DOI: 10.3389/fnins.2022.931161.

Reducing White Adipose Tissue Browning Using p38α MAPK Inhibitors Ameliorates Cancer-Associated Cachexia as Assessed by Magnetic Resonance Imaging.

Zhao Y, Dai J, Jiang Y, Wu H, Cui Y, Li X Nutrients. 2022; 14(15).

PMID: 35893867 PMC: 9331061. DOI: 10.3390/nu14153013.

References

Vogt M, Bruning J . CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age. Trends Endocrinol Metab. 2012; 24(2):76-84. DOI: 10.1016/j.tem.2012.11.004. View

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

Zhang X, Xu A, Chung S, Cresser J, Sweeney G, Wong R . Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes. 2011; 60(2):486-95. PMC: 3028348. DOI: 10.2337/db10-0650. View

Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka T . Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem. 2004; 279(44):45803-9. DOI: 10.1074/jbc.M406963200. View

Gehart H, Kumpf S, Ittner A, Ricci R . MAPK signalling in cellular metabolism: stress or wellness?. EMBO Rep. 2010; 11(11):834-40. PMC: 2966959. DOI: 10.1038/embor.2010.160. View

Imbernon M, Beiroa D, Vazquez M, Morgan D, Veyrat-Durebex C, Porteiro B . Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology. 2012; 144(3):636-649.e6. PMC: 3663042. DOI: 10.1053/j.gastro.2012.10.051. View

Sabio G, Cavanagh-Kyros J, Ko H, Jung D, Gray S, Jun J . Prevention of steatosis by hepatic JNK1. Cell Metab. 2009; 10(6):491-8. PMC: 2804105. DOI: 10.1016/j.cmet.2009.09.007. View

Pirianov G, Brywe K, Mallard C, Edwards A, Flavell R, Hagberg H . Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. J Cereb Blood Flow Metab. 2006; 27(5):1022-32. DOI: 10.1038/sj.jcbfm.9600413. View

Yoon S, Park D, Ryu J, Ozer H, Tep C, Shin Y . JNK3 perpetuates metabolic stress induced by Aβ peptides. Neuron. 2012; 75(5):824-37. PMC: 3438522. DOI: 10.1016/j.neuron.2012.06.024. View

10.

Klover P, Zimmers T, Koniaris L, Mooney R . Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes. 2003; 52(11):2784-9. DOI: 10.2337/diabetes.52.11.2784. View

11.

Czaja M . JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab. 2010; 21(12):707-13. PMC: 2991513. DOI: 10.1016/j.tem.2010.08.010. View

12.

Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban P . Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet. 1999; 23(1):99-103. DOI: 10.1038/12703. View

13.

Jonas J, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R . Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem. 1999; 274(20):14112-21. DOI: 10.1074/jbc.274.20.14112. View

14.

Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui T . JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell. 2004; 13(3):329-40. DOI: 10.1016/s1097-2765(04)00028-0. View

15.

Sabio G, Kennedy N, Cavanagh-Kyros J, Jung D, Ko H, Ong H . Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol Cell Biol. 2009; 30(1):106-15. PMC: 2798290. DOI: 10.1128/MCB.01162-09. View

16.

Gavrilova O, Graham D, Kim J, Shulman G, Castle A, Vinson C . Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 2000; 105(3):271-8. PMC: 377444. DOI: 10.1172/JCI7901. View

17.

Enslen H, Brancho D, Davis R . Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 2000; 19(6):1301-11. PMC: 305671. DOI: 10.1093/emboj/19.6.1301. View

18.

Sumara G, Formentini I, Collins S, Sumara I, Windak R, Bodenmiller B . Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell. 2009; 136(2):235-48. PMC: 2638021. DOI: 10.1016/j.cell.2008.11.018. View

19.

Bogoyevitch M, Kobe B . Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev. 2006; 70(4):1061-95. PMC: 1698509. DOI: 10.1128/MMBR.00025-06. View

20.

Sabio G, Cerezo-Guisado M, Del Reino P, Inesta-Vaquera F, Rousseau S, Arthur J . p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock. J Cell Sci. 2010; 123(Pt 15):2596-604. PMC: 2908048. DOI: 10.1242/jcs.066514. View